Earnings Alerts

Procter & Gamble Co (PG) Earnings: Dip in 3Q Net Income and Revenue Y/Y

  • P&G Health 3Q net income is accounted to be 465.6 million rupees.
  • This figure represents a decrease of 21% from the previous year’s net income of 591.9 million rupees.
  • The revenue for this quarter was 2.52 billion rupees indicating a 21% decrease year over year.
  • However, the total costs were also down by 22%, being 1.92 billion rupees year over year.
  • All original data is based on the company’s original disclosures.
  • For this quarter there were no buy, hold or sell recommendations.

Procter & Gamble Co on Smartkarma

Analyst coverage of Procter & Gamble Co on Smartkarma reveals positive sentiment from Baptista Research analysts. In the report titled “The Procter & Gamble Company: What Are Our Growth Expectations For P&G In A Highly Dynamic Market? – Major Drivers,” the company is commended for strong sales and market share results driven by an integrated strategy. Procter & Gamble’s fiscal performance for the first three quarters of fiscal ’24 exceeded expectations, with an increased outlook for core earnings per share and meeting guidance ranges for organic sales growth and cash return to shareholders.

Another report by Baptista Research, “Procter & Gamble – Continued Growth Potential In China Boosting The Top-Line? – Major Drivers,” highlights the company’s solid performance in achieving organic sales growth and market share despite challenges. The analysts point to the company’s diverse portfolio, innovation efforts, and sustainability initiatives as key drivers of its success. Procter & Gamble reported a strong quarter, with a 4% growth in organic sales and a 16% increase in core earnings per share, indicating a positive outlook for future performance.


A look at Procter & Gamble Co Smart Scores

FactorScoreMagnitude
Value2
Dividend3
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Procter & Gamble Co, a global consumer products manufacturer known for its household brands, has received a mix of Smartkarma Smart Scores. While the company scores reasonably well in terms of dividend, growth, resilience, and momentum, its value score falls slightly behind. The company’s diverse product portfolio spans across various segments including laundry and cleaning, beauty care, and healthcare, among others. Procter & Gamble products are widely distributed through various retail channels worldwide.

Looking ahead, Procter & Gamble Co‘s overall outlook appears positive based on the Smartkarma Smart Scores. With strong momentum and resilience, the company is positioned well for long-term growth and potential returns. Investors may find value in Procter & Gamble’s consistent dividend payments and steady growth trajectory, despite the moderate value score. As the company continues to innovate and expand its presence in global markets, it remains a prominent player in the consumer products industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars